I am a breastfeeding mother and i want to know if it is safe to use (R)-N-2-Propynyl-1-indanamine? Is (R)-N-2-Propynyl-1-indanamine safe for nursing mother and child? Does (R)-N-2-Propynyl-1-indanamine extracts into breast milk? Does (R)-N-2-Propynyl-1-indanamine has any long term or short term side effects on infants? Can (R)-N-2-Propynyl-1-indanamine influence milk supply or can (R)-N-2-Propynyl-1-indanamine decrease milk supply in lactating mothers?

- DrLact safety Score for (R)-N-2-Propynyl-1-indanamine is 7 out of 8 which is considered Dangerous as per our analyses.
- A safety Score of 7 indicates that usage of (R)-N-2-Propynyl-1-indanamine may cause toxic or severe side effects in breastfed baby.
- Our study of different scientific research indicates that (R)-N-2-Propynyl-1-indanamine may cause moderate to high side effects or may affect milk supply in lactating mother.
- Our suggestion is to use safer alternate options rather than using (R)-N-2-Propynyl-1-indanamine .
- Usage of (R)-N-2-Propynyl-1-indanamine is in contradiction to breastfeeding hence if it is must to use (R)-N-2-Propynyl-1-indanamine and there is no better alternative available then breastfeeding shall be stopped permanently or temporarily.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
It a selective MAO-B inhibitor that increases Dopamine serum concentration and inhibits Prolactin secretion and hence decreasing the breast milk production.
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.